Table 1 Clinical characteristics of IgAN patients and controls
From: Genome-wide association study identifies new susceptible loci of IgA nephropathy in Koreans
Discovery cohort | Validation cohort | |||
|---|---|---|---|---|
IgAN (n = 188) | Control (n = 455) | IgAN (n = 310) | Control (n = 438) | |
Age (yrs) | 36.1 ± 13.6 | 54.9 ± 16.3 | 44.1 ± 13.6 | 40.0 ± 5.1 |
Sex (n, M:F) | 83: 105 | 210: 245 | 162: 148 | 255: 183 |
Pathologic stage (HS lee classification) | 2.24 ± 1.02 | ND | ND | ND |
Creatinine (mg/dl) | 1.00 ± 0.33 | ND | 1.49 ± 1.47 | ND |
24 h urine protein (mg/day) | 1728.91 ± 2017.08 | ND | 1161.01 ± 1546.28 | ND |